Managed Healthcare Executive interviewed OneHome’s Noel Gilliam, Vice President of Value-Based Product Design, to discuss the ...

Newly analyzed data from Japan adds to the evidence that COVID-19 may increase the risk of shingles.

Education on biosimilar safety and effectiveness, and automatic substitution laws, are essential for increased uptake.

This trial represents the first major advancement in second-line GIST treatment in over two decades, potentially transforming the therapeutic landscape. Cogent Biosciences announced positive results ...

Fenebrutinib shows promise as the first BTK inhibitor for both RMS and PPMS, reducing relapses and slowing disability progression. The FENhance 2 study demonstrated fenebrutinib's efficacy over ...

Growth hormone receptor (GHR) signaling in bladder cancer is associated with advanced tumor stages and poor survival outcomes. High GHR expression in tumors up-regulates genes involved in drug ...